Skin markers recalled due to storage temperature exposure
Mckesson Medical-Surgical Inc. recalls skin markers used in medical imaging that may have been exposed to excessive temperatures during storage prior to delivery. Affected units were received between June and September 2021.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class III device recall with a precautionary basis: no illnesses or injuries have been reported, and the FDA explicitly states the temperature deviation is 'not likely to cause adverse health consequences.' The hazard—potential product effectiveness degradation—is theoretical, placing this in the 'voluntary precautionary recall' category per the rubric.
Plain-English summary
Mckesson Medical-Surgical Inc. is recalling two types of skin markers used in medical imaging procedures: the IZI Medical Products Multi-Modality Markers (Skin Marker Radio 1.5mm, Catalog #MM3005) and the Skin Marker Mammo BB2.0 (Catalog #SDM-BB20). These markers are placed on patient skin to identify anatomical landmarks during imaging studies such as mammography and general radiology.
The recall was initiated because the markers experienced temperature excursions—temperatures higher than the recommended storage conditions—between June and August 2021 prior to delivery. Skin markers received by customers between June 1, 2021 and September 30, 2021 are affected. Exposure to elevated temperatures during this period could potentially impact the markers' performance and effectiveness.
According to the FDA, this device with this specific storage temperature deviation is not likely to cause adverse health consequences. Patients and healthcare providers who have used or may use affected markers should be aware of this recall. If you have concerns about whether specific markers are affected by this temperature deviation, contact Mckesson Medical-Surgical Inc.
The recalled product
- Product
- Skin markers: a. IZI MEDICAL PRODUCTS LLC Multi-Modality Markers SKIN MARKER RADIO 1.5MM 50BX Catalog #MM3005. b. SKIN MARKER MAMMO BB2.0 100B - Mammography Skin Marker Catalog # SDM-BB20.
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Medical Device — Imaging Marker
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- GTIN: a. 00815212020766. b. unknown
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 23 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature exposure
See all →- ModerateQuantimetrix Urine Chemistry Control Set Recalled for Temperature Exposure
FDA (Devices) · 2024-10-30
- HighRespiratory inhalation medication recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- ModerateAllopurinol tablets recalled due to improper storage conditions
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03